Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from CMS

Nursing home staff lagging on boosters

One out of seven US COVID-19 deaths has been residents in nursing homes, research has shown

Salon

CMS rule allows states to deduct union dues, benefits from Medicaid payments

On May 12, the Centers for Medicare Medicaid Services (CMS) issued a rule allowing states to make Medicaid payments to third parties, such as for union dues or benefits, on behalf of individual home care providers.

Ballotpedia

CMS Energy's Return on Invested Capital Insights

According to Benzinga Pro data CMS Energy (NYSE:CMS) posted a 45.58% decrease in earnings from Q4. Sales, however, increased by 16.77% over the previous quarter to $2.37 billion.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Medicare surprise: Drug plan prices touted during open enrollment can rise within a month

Something strange happened between the time Linda Griffith signed up for a new Medicare prescription drug plan during last fall’s enrollment period and when she tried to fill her first prescription in January.

Tribune News Service

CMS Energy: Q1 Earnings Insights

CMS Energy (NYSE:CMS) reported its Q1 earnings results on Tuesday, May 3, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Drug plan prices touted during Medicare open enrollment can rise within a month

Even the savviest Medicare drug plan shoppers can get a shock when they fill prescriptions: That great deal on medications in fall is no bargain after prices go up as much as 8% by winter.

WEKU

Earnings Preview For CMS Energy

CMS Energy (NYSE:CMS) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that CMS Energy will report an earnings per share (EPS) of $1.12.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Scots-led dementia research project will give hope to heroes

A new study will see ex-footballer's brain health compared to the general population to provide more research into the link between dementia and the sport.

Daily Record

DWP child maintenance service blasted by single parents over delays in payment

A report released by One Parent Families Scotland painted a damning picture of the child maintenance payment service.

Daily Record

US congressman urges Biden to ban six UK lawyers for ‘enabling’ oligarchs

Steve Cohen says the US must establish ‘deterrents’ against lawyers accused of carrying out ‘unscrupulous work’

The Guardian - UK

Where CMS Energy Stands With Analysts

Within the last quarter, CMS Energy (NYSE:CMS) has observed the following analyst ratings:

Benzinga

North East deals of the week: key investments, contracts and acquisitions

Firms and organisations announcing deals this week include CMS, Dynamo, Felmoor Park and Hirestreet

Birmingham Post

Who doesn’t text in 2022? Most state Medicaid programs

West Virginia will use the U.S. Postal Service and an online account this summer to connect with Medicaid enrollees about the expected end of the COVID-19 public health emergency, which will put many recipients at risk of losing their coverage.

Tribune News Service

Tyneside engineers CMS set for growth following significant investment

The undisclosed package from London-based Newable will help the firm create jobs and invest in staff and training

Birmingham Post

Get all your
news in one place.

100’s of premium titles.
One news app.

Tribune News Service

‘Just as segregated’: What’s next for NC towns after court tosses charter school suit?

CHARLOTTE, N.C. — Gregory “Dee” Rankin plans to keep on fighting even when the only option left is the North Carolina Supreme Court.

Tribune News Service

Commentary: Medicare is cleaning up the FDA’s mess on Biogen’s Alzheimer’s drug

Medicare has decided once and for all not to pay for Biogen’s new Alzheimer’s drug Aduhelm unless patients are enrolled in a clinical study.

The Street

Should Biogen Investors Be Worried About Its Alzheimer's Drug?

A Medicare policy decision might hurt sales of this biotech giant's Alzheimer's drug.

Investors Business Daily

How Medicare 'Snuffed Out' Hope For Biogen's Controversial Alzheimer's Drug

Medicare officially restricted use of Biogen's Alzheimer's treatment, Aduhelm, to patients enrolled in clinical studies.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Morning Brief: Top Stories Dominating Financial Media on Friday, April 8

Reuters

Benzinga

Biogen's Alzheimer's Drug Aduhelm Medicare Coverage Restricted To Just Clinical Trials, CMS Finalizes

Centers for Medicare and Medicaid Services (CMS) finalized its decision to restrict coverage for Biogen Inc's (NASDAQ:&

Axios

Medicare's limits on Aduhelm coverage sparks questions about future drugs

The Biden administration announced Medicare will cover Aduhelm, but will require patients to be enrolled in a clinical trial in order to access the drug.

The Conversation

Jada Pinkett Smith and Black women's hair: History of disrespect leads to the CROWN Act

The fallout from “the slap” at this year’s Oscars continues. Last week, Will Smith resigned from the Academy of Motion Picture Arts and Sciences, after the academy issued a statement condemning Smith’s actions.

The Independent UK

End of COVID may bring major turbulence for US health care

When the end of the COVID-19 pandemic comes, it could create major disruptions for U.S. health care

Manchester Evening News

Parents brand Child Maintenance Service 'an absolute joke' and say it's too easy to dodge payments

Mums have told us of ex partners owing thousands of pounds in arrears

Tribune News Service

Administration faces risks in decision on public health emergency

More than two years into the country’s declared public health emergency, the Biden administration faces a dilemma about whether and when to end it.

1 … 11 12 13 14

People

Ketanji Brown Jackson

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.